Nonalcoholic fatty liver disease and cognitive impairment: A prospective cohort study.
<h4>Background & aims</h4>Nonalcoholic fatty liver disease (NAFLD) is prevalent and may affect cognitive function. We studied associations of NAFLD with risk of cognitive impairment. Secondarily we evaluated liver biomarkers (alanine aminotransferase (ALT), aspartate aminotransferase...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0282633 |
| _version_ | 1797837940957642752 |
|---|---|
| author | Mary Cushman Peter W Callas Kristine S Alexander Virginia Wadley Neil A Zakai Steven D Lidofsky Frederick W Unverzagt Suzanne E Judd |
| author_facet | Mary Cushman Peter W Callas Kristine S Alexander Virginia Wadley Neil A Zakai Steven D Lidofsky Frederick W Unverzagt Suzanne E Judd |
| author_sort | Mary Cushman |
| collection | DOAJ |
| description | <h4>Background & aims</h4>Nonalcoholic fatty liver disease (NAFLD) is prevalent and may affect cognitive function. We studied associations of NAFLD with risk of cognitive impairment. Secondarily we evaluated liver biomarkers (alanine aminotransferase (ALT), aspartate aminotransferase (AST), their ratio, and gamma-glutamyl transpeptidase).<h4>Methods</h4>In a prospective cohort study, the REasons for Geographic and Racial Differences in Stroke, among 30,239 black and white adults aged ≥45,495 cases of incident cognitive impairment were identified over 3.4 years follow up. Cognitive impairment was identified as new impairment in two of three cognitive tests administered every two years during follow up; word list learning and recall, and verbal fluency. 587 controls were selected from an age, race, sex-stratified sample of the cohort. The fatty liver index was used to define baseline NAFLD. Liver biomarkers were measured using baseline blood samples.<h4>Results</h4>NAFLD at baseline was associated with a 2.01-fold increased risk of incident cognitive impairment in a minimally adjusted model (95% CI 1.42, 2.85). The association was largest in those aged 45-65 (p interaction by age = 0.03), with the risk 2.95-fold increased (95% CI 1.05, 8.34) adjusting for cardiovascular, stroke and metabolic risk factors. Liver biomarkers were not associated with cognitive impairment, except AST/ALT >2, with an adjusted OR 1.86 (95% CI 0.81, 4.25) that did not differ by age.<h4>Conclusions</h4>A laboratory-based estimate of NAFLD was associated with development of cognitive impairment, particularly in mid-life, with a tripling in risk. Given its high prevalence, NAFLD may be a major reversible determinant of cognitive health. |
| first_indexed | 2024-04-09T15:32:46Z |
| format | Article |
| id | doaj.art-e5c9dd564e6a41d7bab1ac82d5a0e12f |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-09T15:32:46Z |
| publishDate | 2023-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-e5c9dd564e6a41d7bab1ac82d5a0e12f2023-04-28T05:31:46ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01184e028263310.1371/journal.pone.0282633Nonalcoholic fatty liver disease and cognitive impairment: A prospective cohort study.Mary CushmanPeter W CallasKristine S AlexanderVirginia WadleyNeil A ZakaiSteven D LidofskyFrederick W UnverzagtSuzanne E Judd<h4>Background & aims</h4>Nonalcoholic fatty liver disease (NAFLD) is prevalent and may affect cognitive function. We studied associations of NAFLD with risk of cognitive impairment. Secondarily we evaluated liver biomarkers (alanine aminotransferase (ALT), aspartate aminotransferase (AST), their ratio, and gamma-glutamyl transpeptidase).<h4>Methods</h4>In a prospective cohort study, the REasons for Geographic and Racial Differences in Stroke, among 30,239 black and white adults aged ≥45,495 cases of incident cognitive impairment were identified over 3.4 years follow up. Cognitive impairment was identified as new impairment in two of three cognitive tests administered every two years during follow up; word list learning and recall, and verbal fluency. 587 controls were selected from an age, race, sex-stratified sample of the cohort. The fatty liver index was used to define baseline NAFLD. Liver biomarkers were measured using baseline blood samples.<h4>Results</h4>NAFLD at baseline was associated with a 2.01-fold increased risk of incident cognitive impairment in a minimally adjusted model (95% CI 1.42, 2.85). The association was largest in those aged 45-65 (p interaction by age = 0.03), with the risk 2.95-fold increased (95% CI 1.05, 8.34) adjusting for cardiovascular, stroke and metabolic risk factors. Liver biomarkers were not associated with cognitive impairment, except AST/ALT >2, with an adjusted OR 1.86 (95% CI 0.81, 4.25) that did not differ by age.<h4>Conclusions</h4>A laboratory-based estimate of NAFLD was associated with development of cognitive impairment, particularly in mid-life, with a tripling in risk. Given its high prevalence, NAFLD may be a major reversible determinant of cognitive health.https://doi.org/10.1371/journal.pone.0282633 |
| spellingShingle | Mary Cushman Peter W Callas Kristine S Alexander Virginia Wadley Neil A Zakai Steven D Lidofsky Frederick W Unverzagt Suzanne E Judd Nonalcoholic fatty liver disease and cognitive impairment: A prospective cohort study. PLoS ONE |
| title | Nonalcoholic fatty liver disease and cognitive impairment: A prospective cohort study. |
| title_full | Nonalcoholic fatty liver disease and cognitive impairment: A prospective cohort study. |
| title_fullStr | Nonalcoholic fatty liver disease and cognitive impairment: A prospective cohort study. |
| title_full_unstemmed | Nonalcoholic fatty liver disease and cognitive impairment: A prospective cohort study. |
| title_short | Nonalcoholic fatty liver disease and cognitive impairment: A prospective cohort study. |
| title_sort | nonalcoholic fatty liver disease and cognitive impairment a prospective cohort study |
| url | https://doi.org/10.1371/journal.pone.0282633 |
| work_keys_str_mv | AT marycushman nonalcoholicfattyliverdiseaseandcognitiveimpairmentaprospectivecohortstudy AT peterwcallas nonalcoholicfattyliverdiseaseandcognitiveimpairmentaprospectivecohortstudy AT kristinesalexander nonalcoholicfattyliverdiseaseandcognitiveimpairmentaprospectivecohortstudy AT virginiawadley nonalcoholicfattyliverdiseaseandcognitiveimpairmentaprospectivecohortstudy AT neilazakai nonalcoholicfattyliverdiseaseandcognitiveimpairmentaprospectivecohortstudy AT stevendlidofsky nonalcoholicfattyliverdiseaseandcognitiveimpairmentaprospectivecohortstudy AT frederickwunverzagt nonalcoholicfattyliverdiseaseandcognitiveimpairmentaprospectivecohortstudy AT suzanneejudd nonalcoholicfattyliverdiseaseandcognitiveimpairmentaprospectivecohortstudy |